Biotage Launches TurboVap® 96 Dual Evaporator
January 25, 2022
UPPSALA, Sweden -- Biotage is pleased to announce the launch of a sophisticated well plate evaporator, the TurboVap® 96 Dual – a second-generation system with two separate, and independently controlled evaporation compartments, building upon the reputable foundation of the Biotage TurboVap® product line. The new TurboVap® 96 Dual has been designed to support enhanced well-plate evaporation within [...]
Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics
January 25, 2022
SAN FRANCISCO-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Artisan Development Labs Inc. (DBA Artisan Bio), an immune cell engineering company developing next-generation cell therapies, today announced a collaboration to discover novel antibodies against five undisclosed targets, with an [...]
January 24, 2022
Shimadzu Corporation announces the release of the MALDI-8030, further consolidating Shimadzu’s status as a world leader in the market segment for benchtop matrix-assisted laser-desorption/ionization time-of-flight (MALDI-TOF) mass spectrometers. Similar to the class-leading MALDI-8020, the MALDI-8030 uses an identical innovative instrument design – based on the award-winning sleek design - to produce a compact footprint, whilst [...]
January 24, 2022
Led by Inovia Capital and TCV, funding brings total investment to $123 million and will expedite expansion of machine learning technology used in 16 of the top 20 pharmaceutical companies Toronto, CANADA — BenchSci, a global leader in machine learning applications for novel medicine development, today announced a $63 million Series C (US $50 Million) [...]
Aldevron Acquires Nature Technology Corporation
January 24, 2022
Acquisition combines Aldevron's leadership in GMP manufacturing with Nature Tech's portfolio of proprietary technologies. Aldevron has acquired Nature Technology Corporation (NTC), a developer of innovative and proprietary plasmid constructs and manufacturing solutions that are used in the field of cell and gene therapy. NTC's nucleic acid-based technologies include NanoplasmidTM, a proprietary vector construct that improves [...]
Instron® Introduces New 3400 and 6800 Series Universal Testing Systems
January 24, 2022
New High Force Floor Models Ranging up to 300 kN Building on a 75 year legacy of excellence in mechanical testing, Instron is proud to announce the capacity expansion of the 3400 and 6800 Series universal testing systems. The all-new 3400 and 6800 Series high force universal testing systems are successors to Instron’s popular 3300 and 5900 Series systems [...]
Stira Pharmaceuticals Selects Xybion Digital to Transform Lab Operations
January 24, 2022
Labwise XD LIMS Cloud Solution is being implemented to digitize lab processes to improve efficiencies and improve compliance for Stira Pharmaceuticals VANCOUVER, BC and PRINCETON, NJ / ACCESSWIRE / January 24, 2022 / Xybion Digital (TSXV:XYBN), a global, low-code SaaS company that enables digital transformation in highly regulated industries like Life Sciences, announced today it has [...]
January 24, 2022
This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies Westbury, NY – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the launch of its Good Manufacturing Practice (GMP) grade human AB serum, a cell culture supplement to enhance the development and manufacturing [...]
NanoMosaic Signs 31K Square Foot Lease and Establishes “Multi-Omics World Headquarters” in Waltham,
January 24, 2022
BOSTON -- NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications has announced that it has signed a lease for a standalone building of 30,880 square feet in Waltham, MA. The company's new "Multi-Omics World Headquarters" is strategically located in an emerging and vibrant biotech hub [...]
SeqOne Genomics closes €20M series A to accelerate the deployment of its genomic medicine platform
January 24, 2022
The funding will drive international deployment of the company’s next generation genomic analysis platform to enable personalized medicine in cancers as well as rare and hereditary diseases. Montpellier – SeqOne Genomics, provider of next genomic analysis solutions for personalized medicine today announced a Series A funding round of €20M. The round, led by Omnes, Merieux [...]

